Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea · Delayed Price · Currency is KRW 4,760.00
+80.00 (1.71%)
Aug 3, 2026, 3:30 PM KST
Dongwha Pharm.Co.,Ltd Market Cap
Dongwha Pharm.Co.,Ltd has a market cap or net worth of 131.94 billion as of August 3, 2026. Its market cap has decreased by -26.20% in one year.
Market Cap
131.94B
Enterprise Value
258.60B
Revenue
501.33B
Ranking
n/a
PE Ratio
6.64
Stock Price
4,760.00
ChartMarket Cap Chart
Since August 28, 1995, Dongwha Pharm.Co.,Ltd's market cap has increased from 72.32B to 131.94B, an increase of 82.42%. That is a compound annual growth rate of 1.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 131.94B | -23.84% |
| Dec 30, 2025 | 173.24B | -0.79% |
| Dec 30, 2024 | 174.62B | -38.57% |
| Dec 28, 2023 | 284.26B | 10.91% |
| Dec 29, 2022 | 256.31B | -36.58% |
| Dec 30, 2021 | 404.12B | -25.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ilyang Pharmaceutical Co.,Ltd | 150.21B |
| Hyundai Pharmaceutical | 148.35B |
| Ilsung Is | 140.08B |
| Jeil Pharmaceutical Co.,Ltd | 137.41B |
| Samil Pharmaceutical Co.,Ltd | 132.50B |
| AptaBio Therapeutics | 129.09B |
| Kyongbo Pharmaceutical | 121.69B |
| SAMSUNG PHARM. Co., LTD. | 116.62B |